摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3,6-di-O-benzyl-5-azido-5-deoxy-α/β-D-glucofuranose | 127708-83-2

中文名称
——
中文别名
——
英文名称
3,6-di-O-benzyl-5-azido-5-deoxy-α/β-D-glucofuranose
英文别名
5-Azido-3,6-di-O-benzyl-5-deoxy-α/β-D-glucofuranose;5-azido-3,6-di-O-benzyl-5-deoxy-D-glucofuranose;5-azido3,6-di-O-benzyl-5-deoxy-D-glucofuranose;(3R,4R,5R)-5-[(1R)-1-azido-2-phenylmethoxyethyl]-4-phenylmethoxyoxolane-2,3-diol
3,6-di-O-benzyl-5-azido-5-deoxy-α/β-D-glucofuranose化学式
CAS
127708-83-2
化学式
C20H23N3O5
mdl
——
分子量
385.42
InChiKey
CSJWWRPDIAJYEY-MGXUXCEGSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.5
  • 重原子数:
    28
  • 可旋转键数:
    9
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.4
  • 拓扑面积:
    82.5
  • 氢给体数:
    2
  • 氢受体数:
    7

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • N-derivatives of 1-deoxy nojirimycin
    申请人:Merrell Dow Pharmaceuticals, Inc.
    公开号:US05252587A1
    公开(公告)日:1993-10-12
    This invention relates to novel N-derivatives of 1-deoxy nojirimycin, to the method for their preparation and to their use in the treatment of diabetes and the use against retro-viruses, particularly in the treatment of acquired immuno-deficiency syndrome (AIDS).
    本发明涉及新的1-去氧诺吉霉素的N-衍生物,其制备方法以及它们在糖尿病治疗和抗逆转录病毒方面的应用,特别是在获得性免疫缺陷综合症(艾滋病)治疗中的应用。
  • Novel alpha-Glucosidase inhibitors
    申请人:MERRELL DOW PHARMACEUTICALS INC.
    公开号:EP0344383A1
    公开(公告)日:1989-12-06
    This invention relates to novel N-derivatives of 1-deoxy-nojirimyoin, to the processes for their preparation and to their end-use applications, particularly as to their use in the treatment of diabetes.
    本发明涉及 1-脱氧野尻yoin的新型 N-衍生物、其制备工艺及其最终用途,特别是在治疗糖尿病方面的应用。
  • Broek, L. A. G. M. van den; Vermaas, D. J.; Kemenade, F. J. van, Recueil des Travaux Chimiques des Pays-Bas, 1994, vol. 113, # 11, p. 507 - 516
    作者:Broek, L. A. G. M. van den、Vermaas, D. J.、Kemenade, F. J. van、Tan, M. C. C. A.、Rotteveel, F. T. M.、et al.
    DOI:——
    日期:——
  • Looking glass inhibitors: scalable syntheses of DNJ, DMDP, and (3R)-3-hydroxy-l-bulgecinine from d-glucuronolactone and of l-DNJ, l-DMDP, and (3S)-3-hydroxy-d-bulgecinine from l-glucuronolactone. DMDP inhibits β-glucosidases and β-galactosidases whereas l-DMDP is a potent and specific inhibitor of α-glucosidases
    作者:Daniel Best、Chen Wang、Alexander C. Weymouth-Wilson、Robert A. Clarkson、Francis X. Wilson、Robert J. Nash、Saori Miyauchi、Atsushi Kato、George W.J. Fleet
    DOI:10.1016/j.tetasy.2010.01.017
    日期:2010.3
    A convenient large-scale synthesis of 1-deoxynojirimyin (DNJ) from D-glucuronolactone involves introduction of azide at C-5 with retention of configuration to give 5-azido-5-deoxy-1,2-O-isopropylidene-alpha-D-glucofuranose as a key intermediate in an overall yield of up to 72%; the same intermediate can be transformed into DMDP (2R,3R,4R,5R)-2,5-bis(hydroxymethyl)pyrrolidine-3,4-diol] and (3R)-3-hydroxy-L-bulgecinine [(2S,3R,4R,5R)-3,4-dihydroxy-5-hydroxymethyl-L-proline]. L-Glucuronolactone, a readily available L-sugar chiron, may similarly be used to access the enantiomers L-DNJ, L-DMDP, and (3S)-3-hydroxy-D-bulgecinine. A comparison of glycosidase inhibition by DMDP (an inhibitor of beta-glucosidases and beta-galactosidases) and L-DMDP (a potent and specific alpha-glucosidase inhibitor) with the corresponding enantiomeric hydroxybulgecinines is reported; DMDP and (3R)-3-hydroxy-L-bulgecinine show weak inhibition of glycogen phosphorylase. (C) 2010 Elsevier Ltd. All rights reserved.
  • Bird, P.; Dolphin, D. H.; Withers, S. G., Canadian Journal of Chemistry, 1990, vol. 68, p. 317 - 322
    作者:Bird, P.、Dolphin, D. H.、Withers, S. G.
    DOI:——
    日期:——
查看更多